"For over 40 years, we've believed that excellent care begins with a skilled and compassionate team of individuals. We have assembled an unmatched team of healthcare professionals dedicated to providing you with the best possible care and services. Your caregiving team consists of a Radiation Oncologist, Radiation Therapists, the Radiation Oncology Nurse, Medical Physicist and a Dosimetrist. Each is committed to you as a patient, treating you as family, and ensuring you are supported from diagnosis to recovery."

During the past decade, Northmain Radiation Oncology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northmain Radiation Oncology" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "Radiation Therapy Oncology Group" with 1 trials as a collaborator and "SWOG Cancer Research Network" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Northmain Radiation Oncology" are "Breast Cancer" (1 trials), "Esophageal Cancer" (1 trials) and "Pancreatic Cancer" (1 trials). Many other conditions were trialed in "Northmain Radiation Oncology" in a lesser frequency.

Most popular intervention types in "Northmain Radiation Oncology" are "Radiation" (3 trials), "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "3-dimensional conformal accelerated partial breast irradiation" (1 trials), "3-dimensional conformal radiation therapy" (1 trials), "MammoSite or other single-entry intracavitary device" (1 trials), "brachytherapy" (1 trials) and "capecitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northmain Radiation Oncology" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Northmain Radiation Oncology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Northmain Radiation Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Northmain Radiation Oncology, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".